Presence of ascites increases the risk of minor complications hernia, diminished mobility, dyspnoea and major ones such as renal failure, hepatorenal syndrome, spontaneous bacterial peritonitis, hepatic hydrothorax or variceal bleeding. Furthermore, treatment of ascites can also cause complicationselectrolyte imbalance, encephalopathy, gynaecomastia (diuretic therapy), decreasing complement and...

Haemorrhage from oesophageal varices is a life threatening emergency with a mortality rate in the order of 30%-50%. In the last three decades there have been many advances in the treatment and prevention of variceal bleeding. Over recent years the introduction of new pharmaceutical agents that reduce portal pressure, endoscopic variceal ligation, transjugular intrahepatic portosystemic shunt, a...

BACKGROUND The dysfunction of misplaced or dislodged endovascular endoprostheses, may be a serious complication, and endovascular removal may be attempted in some cases. CASE REPORT A Viatorr(®) stent-graft (Gore, Flagstaff, AR, USA) is an endoprosthesis designed and commonly used for creation of a transjugular intrahepatic portosystemic shunt (TIPS). Two Viatorrs were accidentally dislodged ...

Acute variceal bleeding continues to be associated with significant mortality. Current standard of care combines hemodynamic stabilization, antibiotic prophylaxis, pharmacological agents, and endoscopic treatment. Rescue therapies using balloon tamponade or transjugular intrahepatic portosystemic shunt are implemented when first-line therapy fails. Rescue therapies have many limitations and are...

Portovascular anomalies are most commonly seen as congenital communications in dogs and cats. Fixation, whether surgical or interventional, should be considered in all cases for which it is possible to improve perfusion to the liver, and ultimately liver function. Medical management before fixation is always recommended. If surgery is not recommended or not possible, long-term medical managemen...

Chylous ascites (CA) is the extravasation of lipid-rich lymphatic fluid into the peritoneal space following trauma or obstruction of the lymphatic system. Refractory cases of cirrhosis-related CA may be amendable to transjugular intrahepatic portosystemic shunting (TIPS). We present a case of TIPS in the setting of refractory CA secondary to cirrhosis of a transplanted liver graft. Following TI...

Polycystic liver disease (PCLD) has long been considered to represent a contraindication to transjugular intrahepatic portosystemic shunt (TIPS) creation, primarily because of the risk of hemorrhage. Three-dimensional (3D) navigation within the enlarged and potentially disorienting parenchyma can now be performed during the procedure with the development of C-arm cone-beam computed tomography, ...

The Transjugular Intrahepatic Portosystemic Shunt (TIPS) is an interventional treatment for cirrhotic patients with portal hyper-tension. In the light of our medical staa's experience, the consequences of TIPS are not homogeneous for all the patients and a subgroup dies in the rst six months after TIPS placement. An investigation for predicting the conduct of cirrhotic patients treated with TIP...

Since Richter's description in the literature in 1989 of the first procedure on human patients, transjugular intrahepatic portosystemic shunt (TIPS) has been worldwide considered as a noninvasive technique to manage portal hypertension complications. TIPS succeeds in lowering the hepatic sinusoidal pressure and in increasing the circulatory flow, thus reducing sodium retention, ascites recurren...

Since the introduction of transjugular intrahepatic portosystemic shunt (TIPS) 10 years ago, it has been used increasingly in the management of portal hypertension and its complications. TIPS is now considered the procedure of choice for management of refractory variceal bleeding. Its role in the management of refractory ascites, hepatic hydrothorax, hepatorenal syndrome, and hepatopulmonary sy...